In the last 5 years, many co-repressors have been identified in eukaryotes that function in a wide range of species, from yeast to Drosophila and humans. Co-repressors are coregulators that are recruited by DNA-bound transcriptional silencers and play essential roles in many pathways including differentiation, proliferation, programmed cell death, and cell cycle. Accordingly, it has been shown that aberrant interactions of co-repressors with transcriptional silencers provide the molecular basis of a variety of human diseases. Co-repressors mediate transcriptional silencing by mechanisms that include direct inhibition of the basal transcription machinery and recruitment of chromatin-modifying enzymes. Chromatin modification includes histone deacetylation, which is thought to lead to a compact chromatin structure to which the accessibility of transcriptional activators is impaired. In a general mechanistic view, the overall picture suggests that transcriptional silencers and co-repressors act in analogy to transcriptional activators and coactivators, but with the opposite effect leading to gene silencing. We provide a comprehensive overview of the currently known higher eukaryotic co-repressors, their mechanism of action, and their involvement in biological and pathophysiological pathways. We also show the different pathways that lead to the regulation of corepressor-silencer complex formation.-Burke, L. J., Baniahmad, A. Co-repressors 2000. FASEB J.
Gene expression in eukaryotes in response to environmental and developmental stimuli is a complex phenomenon involving the coordinated silencing and activation of gene expression by the action of transcriptional repressors and activators. Recently, coregulators have been identified that interact with DNA-bound transcription factors and play essential roles in the action of these transcription factors. Moreover, these coregulator proteins can recruit multiprotein complexes that also function to modulate transcription. Transcriptional coregulators can be subdivided into coactivators, which mediate gene activation, and co-repressors, which mediate gene silencing. We will focus on the action of co-repressors of higher eukaryotes. Co-repressors harbor intrinsic silencing ability and actively repress transcription but do not bind DNA directly. Rather, they are recruited by transcription factors bound to the regulatory regions of target genes and contribute to the silencing ability of transcriptional silencers or repress the transcriptional activity of gene activators.
A large number of co-repressors have been identified ( Table 1) . Co-repressors are not just recruited by a small selection of transcriptional silencers. Rather, they bind to and mediate the function of a wide range of transcriptional regulators. Specific co-repressors are used for a particular transcriptional silencer. Furthermore, specific interactions of particular co-repressors with silencers can lead to additional recruitment of protein complexes that also contain intrinsic repression function, thus increasing the complexity of transcriptional silencing. This is perhaps best illustrated by the various mechanisms used to recruit histone deacetylase (HDAC) enzymes, which are often associated with co-repressor function. Indirect recruitment of HDAC activity involves different interaction partners depending on the transcriptional regulator. One such targeting complex is the SIN3-protein complex, which includes HDAC1 and 2. The SIN3 proteins SIN3A and SIN3B bind directly to various silencers and target the HDAC activity to these repressors (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . The SIN3 complex and the associated HDAC activity can also be recruited by the nuclear receptor co-repressor (NCoR)/silencing mediator for retinoic acid and thyroid hormone receptor (SMRT) and Alien classes of co-repressors to different silencers (5, 6, (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) .
On the other hand, some transcriptional silencers are able to bind directly to HDACs or use both direct and indirect recruitment of HDAC to silence transcription. The retinoblastoma protein (RB) can directly bind to HDACs independently of SIN3 proteins (31) (32) (33) . In addition, RB binds directly to Ski that associates with the SIN3 complex, thus indirectly recruiting HDAC activity (50) . Similarly, the NCoR and SMRT co-repressors bind directly to SIN3 and to HDAC4, 5, and 7, whereas HDAC7 can then recruit the SIN3 proteins (93) (94) (95) . Furthermore, complexes (77) containing HDAC activity are not restricted to SIN3-containing complexes. Another co-repressor complex, the Mi-2/NuRD (nucleosome remodeling and deacetylase) complex, also contains HDAC activity, which is mediated by HDAC1 and 2 but is not associated with the SIN3 proteins (reviewed in refs 96, 97) . Thus, as seen in Table 1 , the same corepressor can associate specifically with different transcription factors and transcriptional silencers can use multiple co-repressors to exert their effect.
BIOLOGICAL ROLE OF CO-REPRESSORS
Co-repressors have been shown to be essential for a wide range of biological pathways and homeostatic mechanisms, including differentiation, development, cell proliferation, and apoptosis. The critical nature of the co-repressor-repressor interaction is also exemplified by the fact that the binding of co-repressors and their function are critical for action by tumor suppressors, cell cycle regulators, and proteins involved in the regulation by the methylation status of DNA. Essential functions of co-repressors in development have been revealed through knockout or mutant alleles in Drosophila and vertebrates (98) . Mutants of groucho, a co-repressor for many of the repressor proteins in the Drosophila embryo, including hairy and dorsal, exhibit severe defects in neurogenesis, segmentation, and initiation of sex determination (63, 68) . Reduction of the levels of Drosophila CtBP (carboxy-terminal binding protein) co-repressor results in severe segmentation and dorsoventral patterning defects, which can be attributed to loss of repression activity of Krüppel, Knirps, and Snail (77) . The ecdysone receptor/ultraspiracle heterodimer, a critical regulator of molting and metamorphic processes, silences transcription by recruitment of the co-repressors Alien and SMRTER (SMRT-related ecdysone receptor interacting protein) (30, 57) . A mutation in the ecdysone receptor that results in loss of co-repressor interaction and silencing is characterized by developmental abnormalities and lethality (57) . In Xenopus the homologue of dCtBP, XCtBP, is a co-repressor for XTcf-3 that mediates dorsal ventral axis formation. Expression of a mutant XCtBP that has activation rather than silencing function indicates a critical role for XCtBP in the regulation of head and notochord development (80) .
In vertebrates, the SIN3 proteins and the associated HDAC activity have been shown to associate directly with a number of transcriptional repressors involved in essential cell functions. The Myc/Mad family of basic helix-loop-helix (bHLH) proteins are transcription factors that mediate diverse cellular functions including proliferation, differentiation and apoptosis (reviewed in ref 99) . Mad-Max heterodimers silence genes that are activated by MycMax and thus antagonize Myc action. The Mad/Maxsilencer binds to the SIN3 co-repressor complex, which also includes the co-repressors NCoR, Ski, and HDACs (1, 2, 100 -102). The essential role of the two SIN3 proteins, SIN3A and SIN3B, in cellular transformation by the Mad transcription factor is underlined by the observation that deletion of the carboxyl terminus of SIN3B results in loss of transforming potential of the Mad family (100) .
SIN3A itself and the SIN3 co-repressor complex are also associated with the Ikaros family of proteins, which regulate B and T cell differentiation and proliferation of differentiated thymocytes and mature T cells (reviewed in ref 103) . The Ikaros family of proteins have been shown to be associated with two types of HDAC complexes, the SIN3 co-repressor complex and the Mi-2/NuRD complex; Ikaros can recruit the Mi-2/NuRD complex to the heterochromatic regions (11, 52) . The role of these complexes in the functions of the Ikaros family of proteins, however, is at present unclear.
The two co-repressor complexes SIN3 and Mi-2/ NuRD are also involved in transcriptional silencing mediated by methylated DNA. The presence of methyl-cytosines in CpG groups has long been associated with tissue and developmental specific gene regulation. Recently, factors containing a methyl binding domain (MBD) have been shown to recruit HDAC activity and chromatin remodeling activities to methyl-CpGs (reviewed in ref 104). MeCP2, which specifically binds methyl-CpGs, mediates transcriptional repression by a carboxyl-terminal repression domain through interaction with the co-repressor SIN3A and recruits HDACs (7, 8) . This provided the first functional link between the presence of methylCpGs and transcriptional repression. Since then, other repressing complexes involving MBD-containing proteins have been identified. The MeCP1 complex that binds to methylated DNA contains the methyl binding protein MBD2 along with HDAC activity (105), whereas MBD3 is part of the Mi-2/ NuRD complex (54, 106) . The de novo DNA methyltransferase, Dnmt1, has also been shown to contain a repression domain that associates with HDACs (42).
The two tumor suppressor proteins, p53 and RB, which are involved in cell cycle control and apoptosis, also rely on the SIN3 co-repressor complex for their action. Both tumor suppressor proteins are targets of viral oncoproteins. RB is a major regulator of the cell cycle at the G1/S phase boundary. RB forms a complex with c-Ski, Sin3A, and HDACs via direct binding to c-Ski and HDACs (31) (32) (33) 50) . Furthermore, RB and the related protein, p130, also recruit the CtBP/CtIP complex (82), indicating that there are multiple mechanisms operating at the level of RB-mediated transcriptional repression ( Table 1) . The p53 protein is often mutated in tumors and has the dual function to activate and repress genes. The activity of p53 is stimulated by a variety of agents to induce apoptosis or programmed cell death (reviewed in ref 107) . This p53-dependent apoptosis is specifically inhibited by the HDAC inhibitor trichostatin A (TSA) (10), indicating a critical role of HDACs in the apoptotic process. During apoptosis, p53 silences the expression of various genes, including the microtubule-associated protein Map4 (108) . This silencing of Map4 expression involves the recruitment of SIN3 proteins and the associated HDAC activity that leads to a p53-dependent deacetylation of nucleosomes of the Map4 promoter (10) .
The SIN3 co-repressor complex is also associated with gene silencing by nuclear hormone receptors (NHRs). NHRs are ligand-regulated transcription factors that control key processes in development, differentiation, and homeostasis. Some members of this superfamily have the dual role to silence gene expression in the absence of ligand and to activate gene transcription in the presence of their cognate hormone (109) . Silencing is mediated, at least in part, by the hormone-sensitive interaction with the co-repressor proteins NCoR (16), SMRT (15, 110, 111) , and with Alien (30) , which bind to the SIN3 proteins and recruit HDAC activity.
The SMRT/NCoR co-repressor class is not specific for the NHR superfamily (Table 1) . SMRT is also a co-repressor for POZ domain-containing transcriptional silencers such as PLZF, which is involved in leukemia-associated translocations, and BCL6, which is involved in germinal center formation (5, 19 -24) . The homeo domain-containing protein Rpx, which plays a role in pituitary determination, requires NCoR, the SIN3 proteins, and HDAC2 for repression activity (27) . NCoR is also necessary for the activity of the Mad protein/SIN3 complex (100, 101). In addition, NCoR interacts with the myogenic factor MyoD and represses MyoD-mediated trans-activation by an HDAC-dependent mechanism (25) . Moreover, specific functions of MyoD, including differentiation of C2C12 cells and MyoD-mediated myogenic conversion of pluripotent precursor cells, can be blocked by NCoR.
Co-repressors are also a major determinant for cell-specific gene expression. Changes in the relative abundance of co-repressors or the cell-specific expression of co-repressors may determine the relative contribution of co-repressors to transcriptional repression mediated by specific receptors. It has been demonstrated that limiting amounts of the SMRT co-repressor compromises RAR-mediated but not TR-mediated silencing (112) . Thus, the level of certain cellular co-repressors can control the hormonal response, and therefore modulating target gene expression. Furthermore, cell-specific expression of mSiah2 that promotes NCoR degradation also determines the ability of NHRs to function as repressors in specific cell types (113) .
Thus, co-repressors are essential factors in gene regulation at all levels of biological pathways.
CO-REPRESSORS AND DISEASES
Regulation of co-repressor interaction with the DNAbound transcriptional silencer partner is an important and critical parameter for normal biological function. Aberrant interaction of co-repressors can lead to severe pathophysiological manifestations. Several human diseases are a consequence of either enhanced or reduced co-repressor-silencer interactions.
An enhanced co-repressor-transcription factor interaction has been associated with many forms of leukemia. Several types of leukemia result from translocations involving fusions to transcriptional silencers (for review, see ref 114) . Increased corepressor binding to these fusion proteins leads to inappropriate repression of target genes important for normal cellular differentiation.
The AML-1 gene is the target of chromosomal translocations that have been associated with leukemia. Acute myelogenic leukemia (AML) has been shown to involve the chromosomal translocation t(8;21), which fuses the DNA binding domain of the AML protein to the transcriptional repressor ETO/ MTG8. Similarly, B cell acute lymphoblastic leukemia (ALL) involves the chromosomal translocation t(12;21), which results in the fusion of the repression domain of the ets-leukemia protein TEL to the large form of AML, AML-1B. AML-1 normally activates and represses target gene expression when bound to DNA. However, fusion proteins of AML-1 display abnormal transcriptional properties and act mainly as repressors on promoters. This function arises from the recruitment of NCoR and the SIN3-HDAC complex by ETO (6, 17, 18) and TEL (9, 115 ). An inhibitor of HDAC1, phenylbutyrate, partially reverses this ETO-mediated transcriptional repression and is also able to induce partial differentiation of an AML1-ETO cell line (116) . This highlights the importance of the transcriptional repression by HDACs in the development of leukemia.
The three chromosomal translocations t(11;17), t(15;17), and t(5;17) involved in acute promyelocytic leukemia (APL) result in fusion of the promyelocytic leukemia zinc finger protein PLZF, the promyelocytic leukemia protein PML, or nucleophosmin, respectively (117) , to RAR (reviewed in ref 118). All of the resulting fusion proteins have been shown to play important roles in leukemogenesis. These fusion proteins are able to bind to RAR target sequences and repress transcription. The wild-type, unfused RAR represses genes in the absence of its cognate ligand due to recruitment of co-repressors, whereas in the presence of its ligand, all-trans retinoic acid (t-RA), RAR activates target genes by recruitment of coactivators. As expected, both the RAR-PML and RAR-PLZF fusion proteins recruit the NCoR/SMRT co-repressors and the associated HDACs via the SIN3 co-repressor in the absence of ligand (24, 119, 120) . However, the fusion receptors exhibit a reduced responsiveness to retinoic acid and thus target genes remain repressed (Fig. 1) even in the presence of endogenous blood levels of t-RA. After treatments with pharmacological levels of t-RA, patients with the PML-RAR␣ fusion protein have complete, if somewhat transient, remission of leukemia. This correlates with co-repressor dissociation from RAR␣ at higher concentrations of t-RA. However, patients with the PLZF-RAR␣ translocation are unresponsive to higher doses of t-RA (24, 120, 121) . This is related to the ability of the PLZF moiety to retain co-repressors. Upon treatment with t-RA, co-repressors dissociate from the RAR␣ part of the fusion protein, whereas the PLZF part remains attached to the co-repressor SMRT (23) .
Furthermore, HDAC inhibitors, in combination with t-RA, can overcome the transcriptional repressor activity as well as the unresponsiveness of PLZF-RAR␣-expressing leukemic cells to t-RA (24, 119, 120) . After a period of time, patients with PML-RAR␣ fusions become refractive to t-RA treatment. This refractiveness can be overcome with sodium phenylbutyrate, an inhibitor of HDACs, which results in clinical and cytogenetic remission shortly after treatment (122) . This points to the potential of a combined treatment of APL patients with t-RA and HDAC inhibitors for more successful therapy.
Increased stability of a co-repressor-silencer complex is also involved in the thyroid hormone resistance syndrome (THR). This syndrome is inherited in an autosomal dominant manner and is due to mutations of the thyroid hormone receptor (TR) ␤, a member of the NHR superfamily (118, (123) (124) (125) . Patients with this syndrome have a short physical stature due to a delay in bone growth and exhibit hearing defects, learning disabilities, and mental retardation. Furthermore, patients have higher levels of thyroid hormone, although symptoms of hypothyroidism are manifested. Point mutations in TR␤ reduce or completely abolish thyroid hormone binding capability, whereby the receptor remains in the Figure 1 . Abnormal development and cancer result from aberrant co-repressor-silencer interaction. Several human diseases are based on aberrant co-repressor (dark circles) interaction with transcriptional silencers. Loss of co-repressor association has been found to be associated with the Rett syndrome and adrenal hypoplasia. Target genes are unrepressed due to lack of functional transcriptional silencers and co-repressor recruitment. On the other hand, loss of corepressor dissociation is associated with the thyroid hormone resistance (THR) syndrome and leukemia. Genes that are normally expressed thereby remain constitutively silenced.
repressive state (126) and remains attached to corepressors (127, 128) despite higher levels of blood thyroid hormone (Fig. 1) . It is thought that important genes required for normal development and cellular differentiation remain abnormally silenced. Similarly, the oncogene v-ErbA, which is a mutated form of TR␣, induces erythroblastosis and sarcomas through repression of genes that are essential for normal differentiation. The oncogene exhibits constitutive and dysregulated binding to co-repressors, which leads to constitutive silencing function (reviewed in ref 129) .
Examples of human diseases based on loss of co-repressor interaction are represented by mutations of MeCP2, RB, and DAX-1. The latter is an unusual member of the NHR superfamily in that it has a conserved carboxyl-terminal domain, whereas the DNA binding domain differs from other members. Mutations of the DAX-1 gene are associated with adrenal hypoplasia and hypogonadism (130 -133) . DAX-1 is a potent transcriptional silencer of the orphan nuclear receptor steroidogenic factor 1, SF-1, and recruits the nuclear receptor co-repressors NCoR and Alien, but not SMRT. Naturally occurring DAX-1 mutants have lost silencing function, which correlates with loss of interaction with the co-repressors NCoR and Alien (134, 135) (Fig. 1) .
The Rett syndrome is an X-linked progressive neurodevelopmental disorder. The genetic basis of this syndrome are mutations in the X-linked methylCpG binding protein 2, MeCP2, that affect either the methyl binding domain or the trans-repression domain (136) . These mutations result in loss of silencing function and loss of recruitment of the SIN3 co-repressor to target promoters. In these cases, transcriptional silencing of important genes is lost (Fig. 1) .
Naturally occurring mutants of the tumor suppressor protein RB from patients who have developed cancer show that the ability of these mutant RB proteins to repress E2F trans-activation is lost. This results in loss of cell cycle regulation. Accordingly, mutant RBs have been shown to lack interaction with HDACs and have lost silencing function (reviewed in ref 137) . Thus, one mechanism of generating cancer by mutation of the RB gene is the loss of co-repressor interaction and loss of gene silencing.
Other viral oncoproteins also recruit co-repressors and this association is important for disease formation. The oncoprotein E7 is the main transforming protein of human papillomavirus 16, which plays a major role in cervical cancer. E7 has been shown to bind to Mi-2 and HDACs, and this HDAC association is necessary for the growth-promoting effects mediated by the E7 protein (53) .
Thus, co-repressors play an important role in human diseases and the co-repressor-silencer complex formation must be controlled in a stringent fashion.
CO-REPRESSOR ACTION

Mechanisms of co-repressor action on chromatin
A general correlation between histone acetylation status and gene activity has been established (reviewed in ref 138) . It is generally accepted that the acetylation of the lysine residues of the core histone tails is associated with transcriptionally active DNA whereas the deacetylation of these lysine residues is associated with transcriptional repression. The most widely accepted proposal surrounding this observation is that the acetylation of the lysine residues in the core histone tails results in a more open structure of the chromatin. Thereby, chromatin is more readily accessible to transcription factors. Deacetylation results in a more compact chromatin structure and thus decreases accessibility of the chromatin for transcription factors (for review, see ref 139) (Fig. 2) .
Many enzymes that catalyze either histone acetylation (HATs) or histone deacetylation (HDACs) have been identified. The importance of HDAC activity in mediating gene silencing is shown in cases of HDAC1 and HDAC2/mRPD3 for which the HDAC activity is essential for the full functional repression (140, 141) . In higher eukaryotes, seven proteins have been identified so far that possess HDAC activity (37, 38, 94, 142, 143) . These can be divided into two classes based on their sequence homology to yeast proteins and the observation that the homologous proteins in yeast form distinct complexes (144) . Class I HDACs, consisting of HDAC 1-3, share 
HDAC1 and 2 exist as core components of the two deacetylase complexes characterized in eukaryotes: the SIN3 complex and the Mi-2/NuRD complex (reviewed in refs 96, 97). These complexes both contain the four core proteins HDAC1, HDAC2, which possess deacetylase activity (37, 142) , and the retinoblastoma-associated proteins RbAp46 and RbAp48, which appear to target the complex by binding to the histones (145) . The SIN3 complex is composed of the four core proteins and a number of other factors, including the SIN-associated proteins SAP18 and SAP30. The mechanism of action and the biological role of these associated factors in the context of the complex are largely unknown.
The Mi-2/NuRD complex, apart from the core proteins, contains MTA2, a protein that is similar to the metastasis-associated protein MTA-1, the methyl binding domain proteins MBD3a/b, and a protein with chromatin remodeling activities, Mi-2␤/CHD4 (106, 146 -149) . The Mi-2␤ protein is a member of the SWI/SNF family of proteins, which are known to change DNA-histone interactions in an ATP-dependent manner. Traditionally, these ATP-dependent chromatin remodeling activities have been associated with transcriptional activation, but have recently been shown to facilitate transcriptional repression by a yet unknown mechanism. The ability of the NuRD complex to remodel nucleosomes is necessary for deacetylation of oligonucleosomal histone in vitro (149) , suggesting that the remodeling activity in some way influences the access of the deacetylating components of the Mi-2/NuRD complex. Therefore, it has been postulated that the remodeling activities of the Mi-2/NuRD components make the DNA more accessible to the deacetylase and thus promote deacetylation. Thus, co-repressors that recruit these HDACs mediate gene silencing by targeting and modifying chromatin (for review, see ref (150) .
Mechanisms of co-repressor action on the basal transcription machinery
The use of the HDAC inhibitors sodium butyrate and (more recently) the specific inhibitor TSA have been instrumental in the identification of proteins that have an associated HDAC activity. However, it has also been revealed that in some cases not all of the silencing ability of co-repressors could be relieved by these inhibitors (30, 93, 101, 140, 151) . Accordingly, some co-repressors have been shown to use multiple mechanisms to repress gene expression. This includes interaction of co-repressors with factors of the basal transcriptional machinery (Fig. 2) .
RevErb␤, a member of the NHR superfamily, can bind a complex containing the co-repressor NcoR and the basal transcription factors TAFII32, TAFII70, TFIIB, SIN3, and HDAC1. It has been shown that multiple and distinct domains of NCoR are required for the interaction with different members of the basal transcriptional apparatus (152) . Furthermore, the amino-terminal repression domain of NCoR, which can bind to both TFIIB and TAFII32, can disrupt the functional interaction between TAFII32 and TFIIB that is required for transcriptional activation. Similarly, SMRT also harbors multiple repression domains and can interact with both the SIN3 co-repressor and the basal factor TFIIB. This TFIIB interaction correlates with the repression ability of SMRT (153) . Members of the basal transcriptional machinery, including TFIIE and TFIIF, can also be acetylated by histone acetyltransferases (154) . The action of HDACs on the acetylation status of these proteins during transcriptional repression is unknown, although it is conceivable that these proteins may also be targets of HDACs.
Thus, co-repressors act via multiple mechanisms with multiple interaction partners, including the transcriptional apparatus. This implies that a large complex that involves both histone deacetylation and repression of the basal transcriptional machinery (Fig. 2) is very potent for full transcriptional repression.
Repression of transcriptional activators
Not only can co-repressors mediate the silencing effects of DNA-bound silencers, but more and more examples are being presented where co-repressors also associate with previously described transcriptional activators. This association may result in the masking of the activation domain and the displacement of coactivators. In these cases, not only is the activation of the transcription factor reduced, but active gene silencing also results. Thus, under certain conditions a transcription factor can act as a repressor or an activator.
One such example is the modulation of E2F activity by the RB tumor suppressor. In the absence of RB binding, E2F acts as a transcriptional activator. Binding of RB to E2F renders E2F response elements from an activating to a repressive sequence. RB has a dual role in this regulation in that the activation domain of E2F is blocked by RB binding and RB also actively represses transcription (155, 156) by direct recruitment of HDAC1 (31) (32) (33) , c-Ski (50) and CtBP (82) .
MECHANISMS OF SILENCER-CO-REPRESSOR FORMATION
The stringent regulation of the silencer-co-repressor complexes is essential for various important biological functions. The formation or the dissociation of a particular silencer-co-repressor complex is proving to be the next level of complexity in the regulation of transcription factor function. The multiple mechanisms understood so far include ligand binding, DNA-induced specificity, posttranslational modification, proteosomal degradation, competition for cellular factors, and subcellular localization (Fig.  3) .
NHRs that bind ligands recruit co-repressors in a ligand-sensitive manner (reviewed in ref 157 ). In the absence of ligand, these NHRs are bound to response elements in the regulatory regions of target genes in association with co-repressors (NCoR, SMRT, and Alien) and actively repress transcription. After ligand binding, the receptors undergo conformational changes that lead to the dissociation of these co-repressors (15, 16, 158) .
Co-repressor-silencer complex formation can also depend on the architecture of the specific DNA sequence, which is exemplified in case of NHRs (39, 159, 160) . When RAR is bound to a DR5 response element, a direct repeat with five base pair spacing, co-repressors dissociate on ligand binding. On this element RAR is a silencer and a hormone-dependent transcriptional activator. However, on a DR1 element, a direct repeat with one base pair spacing, co-repressors remain bound to the receptor even after binding to ligand. Since coactivators are recruited and co-repressors are not dissociated upon hormone binding, this leads to a transcriptionally inert receptor (159) . Also, on negative TREs, which are named for their ability to repress genes in the presence of thyroid hormone, liganded TR recruits HDAC2 in the presence of ligand (39) . Opposite to that, on classical elements ligand binding to TR leads to dissociation of the co-repressor complex (15, 16, 158) .
Phosphorylation of the silencer proteins can lead to changes in the recruitment of the co-repressors. In early G 1 phase, hypophosphorylated RB represses E2F gene activation by recruitment of HDAC activity (31-33; reviewed in ref 137) . Activation of cdk4/6 cyclin-dependent kinases in late G 1 phase results in hyperphosphorylation of RB and dissociation of the HDAC activity resulting in inactivation of transcriptional repression mediated by RB bound to E2F (161) . NHR co-repressor interactions are also influenced by kinases. Activation of the epidermal growth factor receptor signal transduction pathway inhibits the ability of TR and v-ErbA to repress transcription and to interact with SMRT (162) . Furthermore, this tyrosine kinase activation also inhibits the ability of PLZF to repress transcription and to interact with SMRT, implying that the involvement of tyrosine phosphorylation in regulation of SMRT recruitment is more widespread than just by NHRs.
Proteolysis of co-repressors is also a mechanism that regulates the duration of the co-repressorsilencer complex at the promoter region of the targeted gene. The NH 2 terminus of NCoR can be targeted by mSiah2 for degradation (113) . This mechanism of co-repressor removal, therefore, operates like an antirepressor mechanism. Since the expression of mSiah2 is cell specific, this regulates the ability of NCoR specific receptors such as RevErb to function as repressors in specific cell types. Similarly, the Ski family of proteins are regulated by proteolysis. This family are co-repressors for the SMAD proteins that are involved in tumor growth factor ␤ (TGF␤) -mediated cell signaling (reviewed in ref 163) . TGF␤ can induce the rapid degradation of the two Ski family proteins c-Ski and SnoN probably by the proteosomal pathway, thus allowing activation of SMAD responsive target genes (49) .
Competition for cellular components also regulates the ability of silencers to associate with corepressors. The proteins encoded by the Ski protooncogene family have been shown to be part of a histone deacetylase complex and bind to mSin3A and NCoR/SMRT (102) . Transcriptional silencing by RB and the Mad family requires a complex containing c-Ski, which binds directly to RB and the Mad proteins (50, 102) . The viral counterpart of c-Ski, v-Ski, lacks the SIN3 binding region but can still bind to RB and Mad. After v-Ski expression, RB and Mad proteins will bind v-Ski but fail to recruit the SIN3 factor, leading to abrogation of the silencing mediated by RB or Mad. Cellular localization of the repressor also regulates the binding of co-repressors. TGF␤ receptor activation induces the phosphorylation of SMAD2. This results in the heterodimerization with SMAD4 and the nuclear localization of the SMAD2/4 complex. Once in the nucleus, the SMAD2/4 complex forms a complex with FAST2 on DNA and recruits the homeodomain protein TGIF and histone deacetylase activity to repress SMAD2/4-responsive genes (92) .
Thus, nature has generated multiple mechanisms to regulate the protein complex formation of transcriptional silencers with co-repressors on DNA response elements.
OUTLOOK
Meanwhile, it is generally agreed that transcriptional silencing is as important as transcriptional activation for gene control. This includes not only protein encoding genes, but also RNA polymerase I-and III-regulated genes, which have been shown to be repressed by RB (164, 165) . In general, co-repressors play a major part in gene repression mechanisms. An important insight was gained by revealing that co-repressors harbor or recruit HDAC activity as one major player of gene repression. At this stage, the contribution of either the HDAC activity or the interaction with the basal transcription machinery is still unclear. Using the in vitro transcription system with naked DNA or chromatin templates, the detailed influence of each HDAC activity or the inhibition of basal transcription factors on gene silencing will be able to be determined. Also, silencing mediated by heterochromatic areas, telomeric regions, and other aspects of higher order chromosome structure are presumably based on the involvement of co-repressors. The fact that HDACs are expressed in a tissue and stage-specific manner raises questions of the specificity of HDACs in gene control and the role of each HDAC in development. Future experiments including mice model systems will reveal the biological role of each co-repressor. These findings are also important for cancer therapy by using inhibitors of HDACs. It will be important to develop drugs specific for a particular HDAC and/or peptides to effectively inhibit a specific co-repressor-silencer interaction.
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